Download PDF
Semin Thromb Hemost 2001; 27(6): 605-618
DOI: 10.1055/s-2001-18866
Copyright © 2001 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

The Tissue Factor Pathway in Disseminated Intravascular Coagulation

Bjarne Østerud, Eirik Bjørklid
  • Department of Biochemistry, Institute of Medical Biology, Faculty of Medicine, University of Tromsø, Tromsø, Norway
Further Information

Publication History

Publication Date:
06 December 2001 (online)

    Permissions and Reprints

ABSTRACT

In most instances, tissue factor (TF) exposed to the circulation is the sole culprit underlying the initiation of disseminated intravascular coagulation (DIC), although notable exceptions because of a more direct activation of the coagulation system, by snake venoms, for example, do occur. Peripheral monocytes and subendothelial structures are the potential sources of such TF; in the former, TF emerges on the cell surface on synthesis induction and in the latter it becomes available subsequent to permeability changes or damage to the endothelium. Subendothelial TF is constitutively present in fibroblasts, pericytes, and macrophages and at a higher than normal level in tumor-associated macrophages. This scenario of coagulation activation probably describes the principal events underlying emerging acute DIC states under pathophysiological conditions such as abruptio placentae, septic abortion, amniotic fluid embolization, and pregnancy toxemia. Under disease conditions associated with DIC, the continuous exposure to excess TF typically exhausts the available tissue factor pathway inhibitor (TFPI), leading to rampant thrombin generation, persistent feedback activation of factor XI (FXI) by the generated thrombin, and hence virtually uncheckable ongoing fibrin generation (DIC). Recently, it was shown that patients subject to meningococcal sepsis had comparatively large amounts of mainly monocyte-derived circulating TF-containing microparticles. Because phosphatidylserine (PS) is exposed on such particles, in addition to TF, they probably contribute crucially to DIC during meningococcal sepsis. Although endothelial cells (EC) have been shown to express large amounts of TF in vitro, this observation hardly relates to the situation in vivo, where, in contrast, synthesis and exposure of EC TF is very limited and not likely to be of any significance in emerging and ongoing DIC.

KEYWORD

Disseminated intravascular coagulation - DIC - tissue factor - endothelium - thrombin - tissue factor pathway inhibitor - TFPI

REFERENCES

  • 1 Müller-Berghaus G, ten Cate H, Levi M. Disseminated intravascular coagulation: clinical spectrum and established as well as new diagnostic approaches.  Thromb Haemost . 1999;  82 706-712
    PubMedGoogle Scholar
  • 2 Levi M, de Jonge E, van der Poll T, ten Cate H. Disseminated intravascular coagulation.  Thromb Haemost . 1999;  82 695-705
    PubMedGoogle Scholar
  • 3 Giesen P L, Rauch U, Bohrmann B. Blood-borne tissue factor: another view of thrombosis.  Proc Natl Acad Sci USA . 1999;  96 2311-2315
    Google Scholar
  • 4 Taubman M B, Giesen P L, Schecter A D, Nemerson Y. Regulation of the procoagulant response to arterial injury.  Thromb Haemost . 1999;  82 801-805
    PubMedGoogle Scholar
  • 5 Rauch U, Bonderman D, Bohrmann B. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor.  Blood . 2000;  96 170-175
    PubMedGoogle Scholar
  • 6 Camerer E, Kolsto A B, Prydz H. Cell biology of tissue factor, the principal initiator of blood coagulation.  Thromb Res . 1996;  81 1-41
    CrossrefPubMedGoogle Scholar
  • 7 Mann K G. Biochemistry and physiology of blood coagulation.  Thromb Haemost . 1999;  82 165-174
    PubMedGoogle Scholar
  • 8 Morrissey J H, Fakhrai H, Edgington T S. Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade.  Cell . 1987;  50 129-135
    CrossrefPubMedGoogle Scholar
  • 9 Edgington T S, Mackman N, Brand K, Ruf W. The structural biology of expression and function of tissue factor.  Thromb Haemost . 1991;  66 67-79
    PubMedGoogle Scholar
  • 10 Østerud B, Rapaport S I. Activation of factor IX by the reaction product of tissue factor and factor VII: Additional pathway for initiating blood coagulation.  Proc Natl Acad Sci USA . 1977;  74 5260-5264
    CrossrefPubMedGoogle Scholar
  • 11 Krishnaswamy S. The interaction of human factor VIIa with tissue factor.  J Biol Chem . 1992;  267 23696-23706
    PubMedGoogle Scholar
  • 12 Bazan J F. Structural design and molecular evolution of a cytokine receptor superfamily.  Proc Natl Acad Sci USA . 1990;  87 6934-6938
    PubMedGoogle Scholar
  • 13 Drake T A, Morrissey J H, Edgington T S. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis.  Am J Pathol . 1989;  134 1087-1097
    PubMedGoogle Scholar
  • 14 Rapaport S I, Rao L V. The tissue factor pathway: how it has become a ``prima ballerina''.  Thromb Haemost . 1995;  74 7-17
    PubMedGoogle Scholar
  • 15 Morrissey J H, Macik B G, Neuenschwander P F, Comp P C. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation.  Blood . 1993;  81 734-744
    Google Scholar
  • 16 Rao L V, Rapaport S I. Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation.  Proc Natl Acad Sci USA . 1988;  85 6687-6691
    PubMedGoogle Scholar
  • 17 Hoffman M, Monroe D M, Oliver J A, Roberts H R. Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation.  Blood . 1995;  86 1794-1801
    PubMedGoogle Scholar
  • 18 Hoffman M, Monroe D M, Roberts H R. Cellular interactions in hemostasis.  Haemostasis . 1996;  26 12-16
    PubMedGoogle Scholar
  • 19 Rao L V. Tissue factor as a tumor procoagulant.  Cancer Metastasis Rev . 1992;  11 249-266
    CrossrefPubMedGoogle Scholar
  • 20 Pieters J, Willems G, Hemker H C, Lindhout T. Inhibition of factor IXa and factor Xa by antithrombin III/heparin during factor X activation.  J Biol Chem . 1988;  263 15313-15318
    PubMedGoogle Scholar
  • 21 Ahmad S S, Rawala-Sheikh R, Monroe D M, Roberts H R, Walsh P N. Comparative platelet binding and kinetic studies with normal and variant factor IXa molecules.  J Biol Chem . 1990;  265 20907-20911
    PubMedGoogle Scholar
  • 22 Rapaport S I, Rao L V. Initiation and regulation of tissue factor-dependent blood coagulation.  Arterioscler Thromb . 1992;  12 1111-1121
    CrossrefPubMedGoogle Scholar
  • 23 Broze Jr J G. Tissue factor pathway inhibitor and the revised theory of coagulation.  Annu Rev Med . 1995;  46 103-112
    CrossrefPubMedGoogle Scholar
  • 24 Miletich J P, Majerus D W, Majerus P W. Patients with congenital factor V deficiency have decreased factor Xa binding sites on their platelets.  J Clin Invest . 1978;  62 824-831
    PubMedGoogle Scholar
  • 25 Broze Jr J G. Tissue factor pathway inhibitor and the current concept of blood coagulation.  Blood Coagul Fibrinolysis . 1995;  6(Suppl 1) S7-S13
    PubMedGoogle Scholar
  • 26 ten Cate H, Biemond B J, Levi M. Factor XIa induced activation of the intrinsic cascade in vivo.  Thromb Haemost . 1996;  75 445-449
    PubMedGoogle Scholar
  • 27 Fleck R A, Rao L V, Rapaport S I, Varki N. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody [corrected and republished article originally printed in Thromb Res 1990;57:765-781].  Thromb Res . 1990;  59 421-437
    CrossrefPubMedGoogle Scholar
  • 28 Faulk W P, Labarrere C A, Carson S D. Tissue factor: identification and characterization of cell types in human placentae.  Blood . 1990;  76 86-96
    PubMedGoogle Scholar
  • 29 Flossel C, Luther T, Muller M, Albrecht S, Kasper M. Immunohistochemical detection of tissue factor (TF) on paraffin sections of routinely fixed human tissue.  Histochemistry . 1994;  101 449-453
    CrossrefPubMedGoogle Scholar
  • 30 del Zoppo J G, Yu J Q, Copeland B R. Tissue factor localization in non-human primate cerebral tissue.  Thromb Haemost . 1992;  68 642-647
    PubMedGoogle Scholar
  • 31 Eddleston M, de la Torre C J, Oldstone M B. Astrocytes are the primary source of tissue factor in the murine central nervous system. A role for astrocytes in cerebral hemostasis.  J Clin Invest . 1993;  92 349-358
    CrossrefPubMedGoogle Scholar
  • 32 Lockwood C J, Nemerson Y, Guller S. Progestational regulation of human endometrial stromal cell tissue factor expression during decidualization.  J Clin Endocrinol Metab . 1993;  76 231-236
    CrossrefPubMedGoogle Scholar
  • 33 Edwards R L, Rickles F R, Cronlund M. Abnormalities of blood coagulation in patients with cancer. Mononuclear cell tissue factor generation.  J Lab Clin Med . 1981;  98 917-928
    PubMedGoogle Scholar
  • 34 Semeraro N, Montemurro P, Conese M. Procoagulant activity of mononuclear phagocytes from different anatomical sites in patients with gynecological malignancies.  Int J Cancer . 1990;  45 251-254
    CrossrefPubMedGoogle Scholar
  • 35 Shoji M, Hancock W W, Abe K. Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer.  Am J Pathol . 1998;  152 399-411
    PubMedGoogle Scholar
  • 36 Ueno T, Toi M, Koike M, Nakamura S, Tominaga T. Tissue factor expression in breast cancer tissues: Its correlation with prognosis and plasma concentration.  Br J Cancer . 2000;  83 164-170
    Google Scholar
  • 37 Contrino J, Hair G, Kreutzer D L, Rickles F R. In situ detection of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast disease [see comments].  Nat Med . 1996;  2 209-215
    CrossrefPubMedGoogle Scholar
  • 38 Ruco L P, Pittiglio M, Dejana E, Baroni C D. Vascular activation in the histopathogenesis of Hodgkin's disease: potential role of endothelial tissue factor in intravascular thrombosis and necrosis.  J Pathol . 1993;  171 131-136
    PubMedGoogle Scholar
  • 39 Costantini V, Zacharski L R. Fibrin and cancer.  Thromb Haemost . 1993;  69 406-414
    PubMedGoogle Scholar
  • 40 Abdulkadir S A, Carvalhal G F, Kaleem Z. Tissue factor expression and angiogenesis in human prostate carcinoma [see comments].  Hum Pathol . 2000;  31 443-447
    CrossrefPubMedGoogle Scholar
  • 41 Seto S, Onodera H, Kaido T. Tissue factor expression in human colorectal carcinoma: correlation with hepatic metastasis and impact on prognosis.  Cancer . 2000;  88 295-301
    CrossrefPubMedGoogle Scholar
  • 42 Wijermans P W, Rebel V I, Ossenkoppele G J, Huijgens P C, Langenhuijsen M M. Combined procoagulant activity and proteolytic activity of acute promyelocytic leukemic cells: reversal of the bleeding disorder by cell differentiation.  Blood . 1989;  73 800-805
    PubMedGoogle Scholar
  • 43 Tanaka M, Yamanishi H. The expression of tissue factor antigen and activity on the surface of leukemic cells.  Leuk Res . 1993;  17 103-111
    CrossrefPubMedGoogle Scholar
  • 44 Dechend R, Homuth V, Wallukat G. AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor [see comments].  Circulation . 2000;  101 2382-2387
    CrossrefPubMedGoogle Scholar
  • 45 Estelles A, Gilabert J, Grancha S. Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe preeclampsia.  Thromb Haemost . 1998;  79 500-508
    PubMedGoogle Scholar
  • 46 Sibai B M, Ramadan M K, Usta I. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome) [see comments].  Am J Obstet Gynecol . 1993;  169 1000-1006
    CrossrefPubMedGoogle Scholar
  • 47 Ali J, Yeo A, Gana T J, McLellan B A. Predictors of fetal mortality in pregnant trauma patients.  J Trauma . 1997;  42 782-785
    PubMedGoogle Scholar
  • 48 Goodnight S H, Kenoyer G, Rapaport S I. Defibrination after brain-tissue destruction: A serious complication of head injury.  N Engl J Med . 1974;  290 1043-1047
    CrossrefPubMedGoogle Scholar
  • 49 Gando S, Nakanishi Y, Tedo I. Cytokines and plasminogen activator inhibitor-1 in posttrauma disseminated intravascular coagulation: relationship to multiple organ dysfunction syndrome.  Crit Care Med . 1995;  23 1835-1842
    CrossrefPubMedGoogle Scholar
  • 50 Miller C L, Graziano C, Lim R C, Chin M. Generation of tissue factor by patient monocytes: correlation to thromboembolic complications.  Thromb Haemost . 1981;  46 489-495
    PubMedGoogle Scholar
  • 51 Østerud B, Due Jr J. Blood coagulation in patients with benign and malignant tumours before and after surgery. Special reference to thromboplastin generation in monocytes.  Scand J Haematol . 1984;  32 258-264
    PubMedGoogle Scholar
  • 52 Østerud B. The high responder phenomenon: Enhancement of LPS induced tissue factor activity in monocytes by platelets and granulocytes.  Platelets . 1995;  6 119-125
    PubMedGoogle Scholar
  • 53 Blakowski S A, Zacharski L R, Beck J R. Postoperative elevation of human peripheral blood monocyte tissue factor coagulant activity.  J Lab Clin Med . 1986;  108 117-120
    PubMedGoogle Scholar
  • 54 Takahashi H, Satoh N, Wada K. Tissue factor in plasma of patients with disseminated intravascular coagulation.  Am J Hematol . 1994;  46 333-337
    PubMedGoogle Scholar
  • 55 Kubota T, Andoh K, Sadakata H, Tanaka H, Kobayashi N. Tissue factor released from leukemic cells.  Thromb Haemost . 1991;  65 59-63
    PubMedGoogle Scholar
  • 56 Asakura H, Kamikubo Y, Goto A. Role of tissue factor in disseminated intravascular coagulation.  Thromb Res . 1995;  80 217-224
    CrossrefPubMedGoogle Scholar
  • 57 Koyama T, Nishida K, Ohdama S. Determination of plasma tissue factor antigen and its clinical significance.  Br J Haematol . 1994;  87 343-347
    CrossrefPubMedGoogle Scholar
  • 58 Rivers R P, Hathaway W E, Weston W L. The endotoxin-induced coagulant activity of human monocytes.  Br J Haematol . 1975;  30 311-316
    CrossrefPubMedGoogle Scholar
  • 59 Colucci M, Balconi G, Lorenzet R. Cultured human endothelial cells generate tissue factor in response to endotoxin.  J Clin Invest . 1983;  71 1893-1896
    PubMedGoogle Scholar
  • 60 Brox J H, Østerud B, Bjorklid E, Fenton J W. Production and availability of thromboplastin in endothelial cells: the effects of thrombin, endotoxin and platelets.  Br J Haematol . 1984;  57 239-246
    PubMedGoogle Scholar
  • 61 Galdal K S. Thromboplastin synthesis in endothelial cells.  Haemostasis . 1984;  14 378-385
    PubMedGoogle Scholar
  • 62 Iochmann S, Reverdiau-Moalic P, Beaujean S. Fast detection of tissue factor and tissue factor pathway inhibitor messenger RNA in endothelial cells and monocytes by sensitive reverse transcription-polymerase chain reaction.  Thromb Res . 1999;  94 165-173
    CrossrefPubMedGoogle Scholar
  • 63 Østerud B. Tissue factor expression in monocytes: in vitro compared to ex vivo [in process citation].  Thromb Haemost . 2000;  84 521 Letter-522 Letter
    PubMedGoogle Scholar
  • 64 Gregory S A, Morrissey J H, Edgington T S. Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin.  Mol Cell Biol . 1989;  9 2752-2755
    PubMedGoogle Scholar
  • 65 Mackman N. Regulation of the tissue factor gene.  Thromb Haemost . 1997;  78 747-754
    PubMedGoogle Scholar
  • 66 Østerud B, Bjorklid E. The production and availability of tissue thromboplastin in cellular populations of whole blood exposed to various concentrations of endotoxin. An assay for detection of endotoxin.  Scand J Haematol . 1982;  29 175-184
    PubMedGoogle Scholar
  • 67 Nemerson Y, Giesen P L. Some thoughts about localization and expression of tissue factor.  Blood Coagul Fibrinolysis . 1998;  9(Suppl 1) S45-S47
    PubMedGoogle Scholar
  • 68 Fibach E, Treves A, Korenberg A, Rachmilewitz E A. In vitro generation of procoagulant activity by leukemic promyelocytes in response to cytotoxic drugs.  Am J Hematol . 1985;  20 257-265
    PubMedGoogle Scholar
  • 69 Bouchard B A, Shatos M A, Tracy P B. Human brain pericytes differentially regulate expression of procoagulant enzyme complexes comprising the extrinsic pathway of blood coagulation.  Arterioscler Thromb Vasc Biol . 1997;  17 1-9
    PubMedGoogle Scholar
  • 70 Bach R R. Mechanism of tissue factor activation on cells.  Blood Coagul Fibrinolysis . 1998;  9(Suppl 1) S37-S43
    PubMedGoogle Scholar
  • 71 Wolberg A S, Monroe D M, Roberts H R, Hoffman M R. Tissue factor de-encryption: Ionophore treatment induces changes in tissue factor activity by phosphatidylserine-dependent and -independent mechanisms.  Blood Coagul Fibrinolysis . 1999;  10 201-210
    PubMedGoogle Scholar
  • 72 Niemetz J, Marcus A J. The stimulatory effect of platelets and platelet membranes on the procoagulant activity of leukocytes.  J Clin Invest . 1974;  54 1437-1443
    PubMedGoogle Scholar
  • 73 Lorenzet R, Niemetz J, Marcus A J, Broekman M J. Enhancement of mononuclear procoagulant activity by platelet 12-hydroxyeicosatetraenoic acid.  J Clin Invest . 1986;  78 418-423
    PubMedGoogle Scholar
  • 74 Pellegrini G, Malandra R, Celi A. 12-Hydroxyeicosatetraenoic acid upregulates P-selectin-induced tissue factor activity on monocytes.  FEBS Lett . 1998;  441 463-466
    CrossrefPubMedGoogle Scholar
  • 75 Østerud B, Olsen J O, Wilsgard L. The role of arachidonic acid release and lipoxygenase pathway in lipopolysaccharide-induced thromboplastin activity in monocytes.  Blood Coagul Fibrinolysis . 1990;  1 41-46
    PubMedGoogle Scholar
  • 76 Halvorsen H, Olsen J O, Østerud B. Granulocytes enhance LPS-induced tissue factor activity in monocytes via an interaction with platelets.  J Leukoc Biol . 1993;  54 275-282
    PubMedGoogle Scholar
  • 77 Østerud B. Platelet activating factor enhancement of lipopolysaccharide-induced tissue factor activity in monocytes: requirement of platelets and granulocytes.  J Leukoc Biol . 1992;  51 462-465
    PubMedGoogle Scholar
  • 78 Østerud B, Rao L V, Olsen J O. Induction of tissue factor expression in whole blood: lack of evidence for the presence of tissue factor expression in granulocytes [in process citation].  Thromb Haemost . 2000;  83 861-867
    PubMedGoogle Scholar
  • 79 Breimo E S, Østerud B. Tissue factor associated with platelet/microvesicles.  Hemostasis . 2000;  30 68-69
    PubMedGoogle Scholar
  • 80 Eliassen L T, Rekdal O, Svendsen J S, Østerud B. TNF 41-62 and TNF 78-96 have distinct effects on LPS-induced tissue factor activity and the production of cytokines in human blood cells.  Thromb Haemost . 2000;  83 598-604
    PubMedGoogle Scholar
  • 81 van der Poll T, Jansen P M, Van Zee J K. Tumor necrosis factor-alpha induces activation of coagulation and fibrinolysis in baboons through an exclusive effect on the p55 receptor.  Blood . 1996;  88 922-927
    PubMedGoogle Scholar
  • 82 Li A, Chang A C, Peer G T, Hinshaw L B, Taylor Jr B F. Comparison of the capacity of rhTNF-alpha and Escherichia coli to induce procoagulant activity by baboon mononuclear cells in vivo and in vitro.  Shock . 1996;  5 274-279
    PubMedGoogle Scholar
  • 83 van der Poll T, Levi M, Hack C E. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees.  J Exp Med . 1994;  179 1253-1259
    CrossrefPubMedGoogle Scholar
  • 84 Taylor F B, Chang A C, Peer G. Active site inhibited factor VIIa (DEGR VIIa) attenuates the coagulant and interleukin-6 and -8, but not tumor necrosis factor, responses of the baboon to LD100 Escherichia coli Blood .  1998;  91 1609-1615
    PubMedGoogle Scholar
  • 85 de Jonge E, Dekkers P E, Creasey A A. Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia.  Blood . 2000;  95 1124-1129
    PubMedGoogle Scholar
  • 86 Taylor Jr B F. Studies on the inflammatory-coagulant axis in the baboon response to E. coli: regulatory roles of proteins C, S, C4bBP and of inhibitors of tissue factor.  Prog Clin Biol Res . 1994;  388 175-194
    PubMedGoogle Scholar
  • 87 Ramani M, Ollivier V, Khechai F. Interleukin-10 inhibits endotoxin-induced tissue factor mRNA production by human monocytes.  FEBS Lett . 1993;  334 114-116
    CrossrefPubMedGoogle Scholar
  • 88 van der Poll T, Jansen J, Levi M. Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees.  J Exp Med . 1994;  180 1985-1988
    CrossrefPubMedGoogle Scholar
  • 89 McGehee W G, Rapaport S I, Hjort P F. Intravascular coagulation in fulminant meningococcemia.  Ann Intern Med . 1967;  67 250-260
    PubMedGoogle Scholar
  • 90 Østerud B, Flaegstad T. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavourable prognosis.  Thromb Haemost . 1983;  49 5-7
    PubMedGoogle Scholar
  • 91 Østerud B. Leukocytes, adhesive proteins and disseminated intravascular coagulation: Treatment of DIC with plasma/ leukapheresis?. In: Müller-Berghaus G, Blombäck M, ten Cate JW, eds. DIC: Pathogenesis, Diagnosis and Therapy of Disseminated Intravascular Fibrin Formation Amsterdam: Elsevier 1993: 33-40
    Google Scholar
  • 92 Rivers R P, Cattermole H E, Wright I. The expression of surface tissue factor apoprotein by blood monocytes in the course of infections in early infancy.  Pediatr Res . 1992;  31 567-573
    PubMedGoogle Scholar
  • 93 Nieuwland R, Berckmans R J, McGregor S. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis.  Blood . 2000;  95 930-935
    PubMedGoogle Scholar
  • 94 Almdahl S M, Brox J H, Østerud B. Mononuclear phagocyte thromboplastin and endotoxin in patients with secondary bacterial peritonitis.  Scand J Gastroenterol . 1987;  22 914-918
    PubMedGoogle Scholar
  • 95 Almdahl S M, Østerud B. Experimental gram-negative septicemia: Thromboplastin generation in mononuclear phagocytes from different anatomical sites.  Thromb Res . 1987;  47 37-46
    CrossrefPubMedGoogle Scholar
  • 96 Taylor Jr B F, Chang A, Ruf W. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody.  Circ Shock . 1991;  33 127-134
    PubMedGoogle Scholar
  • 97 Sandset P M, Warn-Cramer B J, Maki S L, Rapaport S I. Immunodepletion of extrinsic pathway inhibitor sensitizes rabbits to endotoxin-induced intravascular coagulation and the generalized Shwartzman reaction.  Blood . 1991;  78 1496-1502
    PubMedGoogle Scholar
  • 98 Creasey A A, Chang A C, Feigen L. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock.  J Clin Invest . 1993;  91 2850-2856
    CrossrefPubMedGoogle Scholar
  • 99 Thomas L, Good R. Bilateral cortical necrosis of kidneys in cortisone treated rabbits following injection of bacterial toxins.  Proc Soc Exp Biol Med . 1951;  76 604-608
    PubMedGoogle Scholar
  • 100 Robinson A J, Rapaport S I, Brown S F. Procoagulant activity of peritoneal leukocytes: Effects of cortisone and endotoxin.  Am J Physiol . 1978;  235 H333-H337
    PubMedGoogle Scholar
  • 101 Østerud B, Tindall A, Olsen J O. Effect of steroids during Escherichia coli endotoxinaemia in rabbits.  Haemostasis . 1989;  19 292-299
    PubMedGoogle Scholar
  • 102 Høgmo P, Østerud B. In vitro effects of HWA and methyprednisolone on lipopolysaccharide (LPS)-induced activation products from human blood cells in whole blood. In: 23rd meeting of the Federation of European Biochemical Societies, August 13-18 FEBS Proceedings. Basel: Bauer-Druck; 1995
    Google Scholar
  • 103 Motsay G J, Alho A, Jaeger T, Dietzman R H, Lillehei R C. Effects of corticosteroids on the circulation in shock: experimental and clinical results.  Fed Proc . 1970;  29 1861-1873
    PubMedGoogle Scholar
  • 104 Hammerschmidt D E, White J G, Craddock P R, Jacob H S. Corticosteroids inhibit complement-induced granulocyte aggregation. A possible mechanism for their efficacy in shock states.  J Clin Invest . 1979;  63 798-803
    PubMedGoogle Scholar
  • 105 Østerud B, Olsen J, Tindall A. The generalized Shwartzman reaction: Effects of corticosteroids on thromboplastin synthesis by monocytes. In: Furth V, ed. Mononuclear Phagocytes, Characteristics Physiology and Function Boston: Martinus Nijhoff 1985: 705-711
    Google Scholar
  • 106 Bone R C, Fisher Jr J C, Clemmer T P. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock.  N Engl J Med . 1987;  317 653-658
    CrossrefPubMedGoogle Scholar
  • 107 Solberg S, Østerud B, Larsen T, Sorlie D. Lack of ability to synthesize tissue factor by endothelial cells in intact human saphenous veins.  Blood Coagul Fibrinolysis . 1990;  1 595-600
    PubMedGoogle Scholar
  • 108 Østerud B, Tindall A, Brox J H, Olsen J O. Thromboplastin content in the vessel walls of different arteries and organs of rabbits.  Thromb Res . 1986;  42 323-329
    CrossrefPubMedGoogle Scholar
  • 109 Erlich J, Fearns C, Mathison J, Ulevitch R J, Mackman N. Lipopolysaccharide induction of tissue factor expression in rabbits.  Infect Immun . 1999;  67 2540-2546
    PubMedGoogle Scholar
  • 110 Semeraro N, Triggiani R, Montemurro P, Cavallo L G, Colucci M. Enhanced endothelial tissue factor but normal thrombomodulin in endotoxin-treated rabbits.  Thromb Res . 1993;  71 479-486
    CrossrefPubMedGoogle Scholar
  • 111 Drake T A, Cheng J, Chang A, Taylor Jr F B. Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis [published erratum appears in Am J Pathol 1993;143:649].  Am J Pathol . 1993;  142 1458-1470
    PubMedGoogle Scholar
      >